About: Melanoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Melanoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

2006 article in The New England Journal of Medicine

Attributes	Values
rdf:type	Item
description	article scientifique publié en 2006 (fr) наукова стаття, опублікована в липні 2006 (uk) im Juli 2006 veröffentlichter wissenschaftlicher Artikel (de) 2006 article in The New England Journal of Medicine (en)
publication date	wds:Q56428909-67EB478C-9CB6-4010-9973-57747090F7A7
publication date	2006-07-06 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56428909-717C1DC9-1B85-4BFD-A8AE-D2536FA7007D
language of work or name	English
cites work	wds:Q56428909-51B0F35C-BD5C-40F2-8FEE-08100A1A50CA
cites work	Mutations of the BRAF gene in human cancer
author name string	wds:Q56428909-0344E91C-52B3-4450-ADD6-C35089D11047 wds:Q56428909-1313B5D2-5022-4E1E-B74D-8CBC829896F1
author name string	Martin C. Mihm Arlo J. Miller
rdfs:label	Melanoma (en)
skos:prefLabel	Melanoma (en)
name	Melanoma (en)
title	wds:Q56428909-5105B392-9FAA-43F5-AF1A-6348BBAE2C67
title	Melanoma (en)
page(s)	wds:Q56428909-27A1B1B9-1D4F-4362-90E9-6B8709E4E158
page(s)	51-65
instance of	wds:Q56428909-9b8da888-222d-4fb7-ac8b-4cd08503dd73 wds:Q56428909-D314CAA2-CAF8-44C2-A9BE-2EE8258C7FF1
instance of	review article scholarly article
PubMed ID	wds:Q56428909-05A40000-47BF-40E3-B398-F225E6BB148F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16822996
PubMed ID	16822996
published in	wds:Q56428909-8E39E581-8FE7-4B39-ACF2-76CE28AA3702
published in	The New England Journal of Medicine
issue	wds:Q56428909-E0F8E635-222B-4C4A-B871-44595D7934B1
volume	wds:Q56428909-FC48546D-AFBB-414B-ADF4-B8D37375B317
issue	1
volume	355
DOI	wds:Q56428909-5C31D48E-6A2D-49C1-BF02-BC3C9700904E
DOI	http://dx.doi.org/10.1056/NEJMRA052166
DOI	10.1056/NEJMRA052166
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56428909
is cites work of	Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene. Melanoma epigenetics: novel mechanisms, markers, and medicines. Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management. Essential Role of microRNA in Skin Physiology and Disease Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma. Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions Vaccination of patients with cutaneous melanoma with telomerase-specific peptides. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging Melanoma exosomes: messengers of metastasis. NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma A new era: melanoma genetics and therapeutics The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression. Overexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA. Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth Treatment of metastatic melanoma: an overview Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach Elastin-elastases and inflamm-aging Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients GLI2-mediated melanoma invasion and metastasis The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma Survivin repression by p53, Rb and E2F2 in normal human melanocytes Melanoma biology and new targeted therapy Cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report Carnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible mechanism for the inhibition of cell migration The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells Ocular diseases in metastatic cutaneous melanoma: review of 108 consecutive patients in two German tertiary centers miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo Malignant melanoma in the 21st century: the emerging molecular landscape The role of phytonutrients in skin health Mortality frequency and trends attributed to melanoma in Brazil from 1980-2005. p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi Sunlight ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. The neural crest: a versatile organ system. Genetic and environmental melanoma models in fish Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma Predictive biomarkers: a paradigm shift towards personalized cancer medicine Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53 ABT-737 synergizes with Bortezomib to kill melanoma cells

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software